Curt R. Hartman joined the Board of Directors in 2026. Curt had an accomplished MedTech career with 22 years at Stryker to include the senior leadership positions of Global Division President for two divisions and Corporate CFO

In 2014 he joined CONMED as President and CEO, where he also served as a Director and Chairman of the Board. He retired from CONMED in December of 2024. He has also served as Chair of the Board for Devicor a Private Equity backed breast cancer diagnostics company and Veran, a venture backed lung cancer diagnostic company. His proven leadership, deep orthopedic and medical device expertise, and extensive board experience will further strengthen Spineart’s ability to innovate, grow, and deliver value to surgeons and patients worldwide.

He is a former military pilot, holds a Bachelor of Science in Aerospace Engineering from the University of Michigan and completed the 9 week in residence AMP Program at Harvard.